Andrew Duncan Penn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Andrew Penn, based in San Francisco, CA, is a Psychiatric-Mental Health Nurse Practitioner . He completed his Master's degree at the University of California, San Francisco, and holds a BA in Psychology from the University of California, Santa Cruz. Since 2006, he has been practicing as a Psychiatric Nurse Practitioner, first at Kaiser Permanente Redwood City Medical Center and more recently has served as a Clinical Professor at the UCSF School of Medicine since 2017 where he divides his time between teaching psychopharmacology, researching psilocybin in psychiatry, and serving as an attending NP in the SF Veterans Administration PMHNP Residency program. His experience includes managing depression, psychotherapy, and mental illness. His recent publications focus on cannabis, psilocybin treatment for major depressive disorder, and psychedelic medicines and nursing. His work has been recognized with several honors, including the Distinction in Teaching award from the UCSF Academic Senate.
Education & Training
- University of California, San FranciscoMasters, 2003 - 2005
- University of California, San Francisco, School of NursingMSc, 2005
- University of California, Santa CruzBA, Psychology, 1994
Awards, Honors, & Recognition
- Teacher of the Year UCSF School of Nursing, 2023
- UCSF Academic Senate - Distinction in Teaching Award UCSF, 2021
- APNA-Janssen Scholar American Psychiatric Nurses Association, 2005
- Join now to see all
Professional Memberships
- American Psychiatric Nurses AssociationMember
Publications & Presentations
PubMed
- 2 citationsA Pragmatic, Person-Centered View of Cannabis in the United States: Pursuing Care That Transcends Beliefs.Hannah G Bosley, Juan M Peña, Andrew D Penn, James L Sorensen, Matthew Tierney
Substance Abuse. 2023-10-01 - 148 citationsSingle-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.Charles L Raison, Gerard Sanacora, Joshua Woolley, Keith Heinzerling, Boadie W Dunlop
JAMA. 2023-09-05 - 2 citationsThe Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice.Cindy A Stein, Andrew Penn, Stephanie Van Hope, Caroline G Dorsen, Mariavittoria Mangini
Journal of Midwifery & Women's Health. 2022-05-01
Journal Articles
- Psychedelics: What to Tell Patients TodayPenn, A, Psych Congress Network Journal, 1/1/2015
- Listening to NursesPenn, A, American Journal of Nursing, 1/1/2013
Books/Book Chapters
Lectures
- Working with psychiatric clients who use cannabis: a focus on harm reductionSanta Cruz Mental Health Department, Santa Cruz, CA - 1/1/2018
- Psychopharmacology for Advance Practice Nurses1/1/2018
- A Walk on the Wild Side or the Right Side? The Role of Psychedelics, Cannabinoids, and Opioids in Psychiatric TreatmentNew Orleans, LA - 1/1/2017
- Join now to see all
Other
- Cannabis and bipolar disorder: What�s helpful? What�s harmful? What�s unknown?International Bipolar Foundation webinar
1/1/2018 - Let�s Lead the Conversation About SuicidePenn, A
https://www.psychcongress.com/blog/let%E2%80%99s-lead-conversation-about-suicide
1/1/2018 - A Turning Point for Psychedelics?Penn, A
https://www.psychcongress.com/blog/turning-point-psychedelics
1/1/2018 - Join now to see all
Office
2 Koret Way
room 511q
San Francisco, CA 94143Phone+1 415-770-9499
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: